Pedro Luis
Sánchez Fernández
Catedrático de Universidad
Fundación Jiménez Díaz
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Fundación Jiménez Díaz (9)
2022
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2021
-
Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity
Cardiovascular research, Vol. 117, Núm. 4, pp. 1132-1143
2020
-
Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy
Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 268-269
2019
-
Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity
Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791
2017
-
Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage
Circulation, Vol. 136, Núm. 14, pp. 1288-1300
-
Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition after Myocardial Infarction
Circulation Research, Vol. 121, Núm. 4, pp. 439-450
2016
-
Patients with calcific aortic stenosis exhibit systemic molecular evidence of ischemia, enhanced coagulation, oxidative stress and impaired cholesterol transport
International Journal of Cardiology, Vol. 225, pp. 99-106
2010
-
Respuesta
Revista Espanola de Cardiologia
2009
-
Pronóstico y manejo de los pacientes con síndrome coronario agudo y enfermedad polivascular
Revista Espanola de Cardiologia, Vol. 62, Núm. 9, pp. 1012-1021